Template:Amyl nitrite: Difference between revisions

Revision as of 23:57, 30 January 2014

Amyl nitrite
Amyl nitrite tablet^® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

@@ Line 7: / Line 7: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Amyl nitrite dosage and administration|Dosage and Administration]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Amyl nitrite dosage forms and strengths|Dosage Forms and Strengths]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Amyl nitrite contraindications|Contraindications]]
@@ Line 27: / Line 25: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Amyl nitrite nonclinical toxicology|Nonclinical Toxicology]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Amyl nitrite clinical studies|Clinical Studies]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Amyl nitrite how supplied storage and handling|How Supplied/Storage and Handling]]